Range
3.67 - 3.79
Vol / Avg.
105.4K/614.6K
Div / Yield
-
52 Wk
2.6 - 5.83
Mkt Cap
177.4M
Payout Ratio
-
Open
3.76
P/E
-
EPS
-1.03
Shares
48M
Outstanding
48M
Total Float
-
load more
Sector: Health Care.Industry: Biotechnology
PhaseBio Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications. The lead product candidate of the company is PB2452, which is a novel reversal agent for the antiplatelet drug ticagrelor, used for the treatment of patients experiencing major bleeding or those who require urgent surgery. It is also developing PB1046 which is a fusion protein for the treatment of pulmonary arterial hypertension. The company is also developing its preclinical product candidate, PB6440, for treatment-resistant hypertension.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.690-0.870 -0.1800
REV30.000K0-30.000K
Q4 2020Est.ActualSurprise
EPS-1.030
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
PHASPhaseBio Pharmaceuticals-1.07%177.4M

PhaseBio Pharmaceuticals Frequently Asked Questions

Q

How do I buy PhaseBio Pharmaceuticals (PHAS) stock?

A

You can purchase shares of PhaseBio Pharmaceuticals (NASDAQ: PHAS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PhaseBio Pharmaceuticals's (PHAS) competitors?

Q

What is the target price for PhaseBio Pharmaceuticals (PHAS) stock?

A

The latest price target for PhaseBio Pharmaceuticals (NASDAQ: PHAS) was reported by Needham on March 16, 2021. The analyst firm set a price target for 19.00 expecting PHAS to rise to within 12 months (a possible 413.51% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PhaseBio Pharmaceuticals (PHAS)?

A

The stock price for PhaseBio Pharmaceuticals (NASDAQ: PHAS) is $3.7 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does PhaseBio Pharmaceuticals (PHAS) pay a dividend?

A

There are no upcoming dividends for PhaseBio Pharmaceuticals.

Q

When is PhaseBio Pharmaceuticals (NASDAQ:PHAS) reporting earnings?

A
PhaseBio Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 10, 2021.
Q

Is PhaseBio Pharmaceuticals (PHAS) going to split?

A

There is no upcoming split for PhaseBio Pharmaceuticals.

Q

What sector and industry does PhaseBio Pharmaceuticals (PHAS) operate in?

A

PhaseBio Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.